The domain-specific, stage-limited impact of the Apolipoprotein E epsilon-4 allele on cognitive functions in Alzheimer's disease

Dementia and Geriatric Cognitive Disorders

Volumn 13, Issue 3, 2002, Pages 125-129

  Kim, K W ^a,b   Jhoo, J H ^b   Lee, J H ^c   Lee, D Y ^a,b   Lee, K U ^c   Youn, J C ^b   Youn, J Y ^b   Woo, Jong Inn ^b  

^a Kyunggi Provincial Hospital for Elderly   (South Korea)

^b Seoul National University Hospital   (South Korea)

^c Kangwon National University College of Medicine   (South Korea)

Author keywords

Alzheimer's disease; Apolipoprotein E; Cognitive functions; Delayed recall; Recognition

Indexed keywords

APOLIPOPROTEIN E4;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; COGNITION; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; TASK PERFORMANCE; WORD RECOGNITION;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; COGNITION; HUMANS; MENTAL RECALL; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PREDICTIVE VALUE OF TESTS; RECOGNITION (PSYCHOLOGY); SEVERITY OF ILLNESS INDEX;

EID: 0036122751     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000048644     Document Type: Article

References (25)

1. Association between apolipoprotein E polymorphism and Alzheimer's disease in Koreans
2. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer disease Meta Analysis Consortium
3. Clinical and neuropsychological characteristics in familial and sporadic Alzheimer's disease: Relation to apolipoprotein E polymorphism
4. Apolipoprotein E genotype influences cognitive 'phenotype' in patients with Alzheimer's disease but not in healthy control subjects
5. Accelerated decline in apolipoprotein E-epsilon4 homozygotes with Alzheimer's disease
6. Apolipoprotein ε4 allele and disease progression in patients with late-onset Alzheimer's disease
7. Apolipoprotein E genotype and rate of decline in probable Alzheimer's disease
8. Apolipoprotein E genotype does not influence rates of cognitive decline in Alzheimer's disease
9. Apolipoprotein E: Non-cognitive symptoms and cognitive decline in late onset Alzheimer's disease
10. Apolipoprotein E epsilon 4 allele, cognitive decline, and deterioration of everyday performance in Alzheimer's disease
11. No association between apolipoprotein E epsilon 4 allele and rate of decline in Alzheimer's disease
12. The absence of an apolipoprotein epsilon4 allele is associated with a more aggressive form of Alzheimer's disease
13. Apolipoprotein E epsilon 4 allele in association with global cognitive performance and CSF markers in Alzheimer's disease
14. Association between apolipoprotein E epsilon4 and the rate of cognitive decline in community-dwelling elderly individuals with and without dementia
15. Apo-E geno-type and verbal deficits in Alzheimer's disease
16. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). I. Clinical and neuropsychological assessment of Alzheimer's disease
17. Pathological verification of ischemic score in differentiation of dementias
18. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease
19. A new clinical scale for the staging of dementia
20. Apolipoprotein E genotyping by one-stage PCR
21. APOE-epsilon4 is associated with less frontal and more medial temporal lobe atrophy in AD
22. Inferior temporal lobe atrophy and APOE genotypes in Alzheimer's disease. X-ray computed tomography, magnetic resonance imaging and Xe-133 SPECT studies
23. Apolipoprotein E epsilon 4 allele and hippocampal volume in twins with normal cognition
24. Reduced size of right hippocampus in 39- to 80-year-old normal subjects carrying the apolipoprotein E epsilon4 allele